1. Outcomes in patients with relapsed or refractory multiple myeloma in a phase I study of everolimus in combination with lenalidomide. (25th April 2014) Authors: Yee, Andrew J.; Hari, Parameswaran; Marcheselli, Raffaella; Mahindra, Anuj K.; Cirstea, Diana D.; Scullen, Tyler A.; Burke, Jill N.; Rodig, Scott J.; Hideshima, Teru; Laubach, Jacob P.; Ghobrial, Irene M.; Schlossman, Robert L.; Munshi, Nikhil C.; Anderson, Kenneth C.; Weller, Edie A.; Richardson... Journal: British journal of haematology Issue: Volume 166:Number 3(2014:Aug.) Page Start: 401 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Patterns of growth factor usage and febrile neutropenia among older patients with diffuse large B-cell non-Hodgkin lymphoma treated with CHOP or R-CHOP: the Intergroup experience (CALGB 9793; ECOG-SWOG 4494). Issue 8 (3rd August 2017) Authors: Morrison, Vicki A.; Weller, Edie A.; Habermann, Thomas M.; Li, Shuli; Fisher, Richard I.; Cheson, Bruce D.; Peterson, Bruce A. Journal: Leukemia & lymphoma Issue: Volume 58:Issue 8(2017) Page Start: 1814 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗